Zhejiang Haisen Pharmaceutical Co Ltd Ordinary Shares - Class A 001367
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- ¥25.84
- Day Range
- ¥25.88–27.58
- 52-Week Range
- ¥17.94–34.79
- Bid/Ask
- ¥27.39 / ¥27.40
- Market Cap
- ¥2.76 Bil
- Volume/Avg
- 2.1 Mil / 1.1 Mil
Key Statistics
- Price/Earnings (Normalized)
- 24.29
- Price/Sales
- 6.64
- Dividend Yield (Trailing)
- 1.83%
- Dividend Yield (Forward)
- 1.83%
- Total Yield
- 1.83%
Company Profile
Zhejiang Haisen Pharmaceutical Co Ltd is engaged in the research and development, production and sales of chemical raw materials and intermediates.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
- Stock Style Box
- Small Growth
- Total Number of Employees
- 636
- Website
- http://www.haisenpharma.com
Comparables
Valuation
|
Metric
|
001367
|
301277
|
301211
|
|---|---|---|---|
Price/Earnings (Normalized) | 24.29 | 23.95 | 28.24 |
Price/Book Value | 2.16 | 2.61 | 1.95 |
Price/Sales | 6.64 | 5.40 | 8.88 |
Price/Cash Flow | 20.57 | 19.02 | 30.89 |
Price/Earnings
001367
301277
301211
Financial Strength
|
Metric
|
001367
|
301277
|
301211
|
|---|---|---|---|
Quick Ratio | 12.42 | 5.50 | 13.43 |
Current Ratio | 14.45 | 5.69 | 14.97 |
Interest Coverage | 624.17 | — | 292.62 |
Quick Ratio
001367
301277
301211
Profitability
|
Metric
|
001367
|
301277
|
301211
|
|---|---|---|---|
Return on Assets (Normalized) | 8.52% | 9.99% | 5.03% |
Return on Equity (Normalized) | 9.16% | 11.36% | 5.42% |
Return on Invested Capital (Normalized) | 7.82% | 11.10% | 3.04% |
Return on Assets
001367
301277
301211
Drug Manufacturers - General Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Eli Lilly and Co
LLY
| Prqnsygzp | Plh | $790.4 Bil | |||
| Johnson & Johnson
JNJ
| Tjqbpwr | Fvv | $388.5 Bil | |||
| AbbVie Inc
ABBV
| Kkzbmyfd | Sjqyz | $344.1 Bil | |||
| Merck & Co Inc
MRK
| Ntrzgdkxb | Gccf | $288.2 Bil | |||
| Roche Holding AG ADR
RHHBY
| Wrjssbztby | Kvzy | $258.7 Bil | |||
| AstraZeneca PLC ADR
AZN
| Qztnxljzzs | Jjth | $242.3 Bil | |||
| Novartis AG ADR
NVS
| Zlqwbgv | Kgc | $234.2 Bil | |||
| Amgen Inc
AMGN
| Cjhbslns | Znz | $173.4 Bil | |||
| Pfizer Inc
PFE
| Nkdwbxyc | Jglh | $164.8 Bil | |||
| Sanofi SA ADR
SNY
| Cpvjkhxm | Nvvw | $144.3 Bil |
United States